Continued awareness and education is needed! In 2016 Pancreatic cancer is expected to claim the lives of 41,780 individuals and reports the lowest survival rate of any major cancer. Are you armed with the facts and knowledge in the advances and treatment of this disease? Advances in treatment provide hope but also increase the complexity of care for the patients. This activity will provide a look at the clinical application of new and emerging therapeutic options for advanced metastatic pancreatic cancer as well as examine steps nurses can take to assure a patient centered approach to treatment.
Supported by educational grants from Celgene Corporation and Aduro Biotech
